Week 48 results from a randomized clinical trial of rilpivirine/ emtricitabine/tenofovir disoproxil fumarate vs. efavirenz/emtricitabine/ tenofovir disoproxil fumarate in treatment-naive HIV-1-infected adults

Calvin Cohen, David Wohl, Jose R. Arribas, Keith Henry, Jan Van Lunzen, Mark Bloch, William Towner, Edmund Wilkins, Ramin Ebrahimi, Danielle Porter, Kirsten White, Ivan Walker, Susan Chuck, Shampa De-Oertel, Todd Fralich

Research output: Contribution to journal › Article › peer-review

109 Scopus citations

Fingerprint

Dive into the research topics of 'Week 48 results from a randomized clinical trial of rilpivirine/ emtricitabine/tenofovir disoproxil fumarate vs. efavirenz/emtricitabine/ tenofovir disoproxil fumarate in treatment-naive HIV-1-infected adults'. Together they form a unique fingerprint.

Medicine & Life Sciences